Old Web
English
Sign In
Acemap
>
Paper
>
Significant Weight Gain in CLL Patients Treated with Ibrutinib: a Potentially Deleterious Consequence of Therapy
Significant Weight Gain in CLL Patients Treated with Ibrutinib: a Potentially Deleterious Consequence of Therapy
2019
AnnaLynn M. Williams
Andrea Baran
Mahlon Schaffer
Jocelyn N.P. Bushart
Lynn Rich
Jeremiah Moore
Paul M. Barr
Clive S. Zent
Keywords:
Diabetes mellitus
Internal medicine
Weight gain
Oncology
Ibrutinib
Immunology
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
6
References
2
Citations
NaN
KQI
[]